advisorsecurities master

ENSCEnsysce Biosciences, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
14819
Ticker
ENSC
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2021-07-01
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
ENSC

Detail

Enriched 2026-08-14 20:47

Market cap
$6,126,236.81
Shares outstanding (class)
15,365,530
Shares outstanding (weighted)
15,365,530
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
10
Location
LA JOLLA, CA
Description

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data